Apyx Medical (APYX) – Analysts’ Recent Ratings Updates

Apyx Medical (NASDAQ: APYX) recently received a number of ratings updates from brokerages and research firms:

  • 11/16/2022 – Apyx Medical had its price target lowered by analysts at Piper Sandler to $3.00.
  • 11/16/2022 – Apyx Medical had its price target lowered by analysts at Craig Hallum to $10.00.
  • 11/11/2022 – Apyx Medical had its price target lowered by analysts at Lake Street Capital from $18.00 to $10.00.
  • 11/10/2022 – Apyx Medical was downgraded by analysts at JMP Securities from an “outperform” rating to a “market perform” rating.
  • 11/10/2022 – Apyx Medical had its price target lowered by analysts at Piper Sandler from $12.00 to $3.00.

Apyx Medical Stock Up 22.9 %

APYX traded up $0.32 during trading on Thursday, reaching $1.72. 450,004 shares of the company’s stock were exchanged, compared to its average volume of 676,608. Apyx Medical Co. has a fifty-two week low of $1.31 and a fifty-two week high of $16.99. The business has a 50 day moving average price of $4.09 and a 200 day moving average price of $5.73. The company has a market capitalization of $59.51 million, a P/E ratio of -3.07 and a beta of 1.52.

Apyx Medical (NASDAQ:APYXGet Rating) last posted its quarterly earnings results on Thursday, November 10th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.05). Apyx Medical had a negative return on equity of 39.82% and a negative net margin of 39.28%. The business had revenue of $9.11 million for the quarter, compared to analyst estimates of $12.00 million. As a group, research analysts forecast that Apyx Medical Co. will post -0.64 EPS for the current year.

Insiders Place Their Bets

In other Apyx Medical news, CEO Charles D. Goodwin II purchased 11,750 shares of the firm’s stock in a transaction on Monday, August 29th. The shares were purchased at an average price of $5.96 per share, for a total transaction of $70,030.00. Following the completion of the purchase, the chief executive officer now directly owns 40,000 shares of the company’s stock, valued at $238,400. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Corporate insiders own 11.60% of the company’s stock.

Institutional Investors Weigh In On Apyx Medical

Several large investors have recently made changes to their positions in APYX. Los Angeles Capital Management LLC grew its holdings in shares of Apyx Medical by 47.9% in the 1st quarter. Los Angeles Capital Management LLC now owns 40,965 shares of the company’s stock worth $268,000 after purchasing an additional 13,260 shares during the last quarter. Banco Santander S.A. bought a new stake in shares of Apyx Medical in the 1st quarter worth about $816,000. Greenwood Capital Associates LLC grew its holdings in shares of Apyx Medical by 132.5% in the 1st quarter. Greenwood Capital Associates LLC now owns 144,293 shares of the company’s stock worth $942,000 after purchasing an additional 82,244 shares during the last quarter. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Apyx Medical by 2.1% in the 1st quarter. Raymond James Financial Services Advisors Inc. now owns 302,606 shares of the company’s stock worth $1,976,000 after purchasing an additional 6,150 shares during the last quarter. Finally, MetLife Investment Management LLC grew its holdings in shares of Apyx Medical by 57.0% in the 1st quarter. MetLife Investment Management LLC now owns 18,314 shares of the company’s stock worth $120,000 after purchasing an additional 6,649 shares during the last quarter. Institutional investors own 60.85% of the company’s stock.

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures.

Featured Stories

Receive News & Ratings for Apyx Medical Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical Co and related companies with MarketBeat.com's FREE daily email newsletter.